Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Widschwendter

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Cancer Research|September 1, 1997
Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cellsC Marth, A G Zeimet, M Widschwendter, et al.
Anticancer Research|January 1, 1996
Interaction of retinoic acid and interferon-alpha in breast cancer cell linesM Widschwendter, G Daxenbichler, F Bachmair, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 29, 1998
Peritoneum and tissues of the female reproductive tract as physiological sources of CA-125A G Zeimet, F A Offner, E Müller-Holzner, et al.
British Journal of Cancer|May 19, 2012
Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer ScreeningE O Fourkala, A Gentry-Maharaj, M Burnell, et al.
Gene Therapy|July 26, 2002
Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomasA G Zeimet, E Müller-Holzner, A Schuler, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 12, 2000
[Guidelines for treatment of breast carcinoma by the Gynecological Oncology Working Group. Gynecological Oncology Working Group]H Concin, W Grünberger, E Kubista, et al.
Anticancer Research|February 24, 2001
Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90KA G Zeimet, S Stadlmann, C Natoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Ascitic interleukin-12 is an independent prognostic factor in ovarian cancerA G Zeimet, M Widschwendter, C Knabbe, et al.
British Journal of Cancer|January 15, 1999
Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitroM Widschwendter, A Widschwendter, T Welte, et al.
Journal of the National Cancer Institute|May 18, 2000
Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancerM Widschwendter, J Berger, M Hermann, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cancer Research|September 1, 1997
Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cellsC Marth, A G Zeimet, M Widschwendter, et al.
Anticancer Research|January 1, 1996
Interaction of retinoic acid and interferon-alpha in breast cancer cell linesM Widschwendter, G Daxenbichler, F Bachmair, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 29, 1998
Peritoneum and tissues of the female reproductive tract as physiological sources of CA-125A G Zeimet, F A Offner, E Müller-Holzner, et al.
British Journal of Cancer|May 19, 2012
Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer ScreeningE O Fourkala, A Gentry-Maharaj, M Burnell, et al.
Gene Therapy|July 26, 2002
Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomasA G Zeimet, E Müller-Holzner, A Schuler, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 12, 2000
[Guidelines for treatment of breast carcinoma by the Gynecological Oncology Working Group. Gynecological Oncology Working Group]H Concin, W Grünberger, E Kubista, et al.
Anticancer Research|February 24, 2001
Peritoneal mesothelial cells as a significant source of ascitic immunostimulatory protein 90KA G Zeimet, S Stadlmann, C Natoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Ascitic interleukin-12 is an independent prognostic factor in ovarian cancerA G Zeimet, M Widschwendter, C Knabbe, et al.
British Journal of Cancer|January 15, 1999
Retinoic acid modulates prolactin receptor expression and prolactin-induced STAT-5 activation in breast cancer cells in vitroM Widschwendter, A Widschwendter, T Welte, et al.
Journal of the National Cancer Institute|May 18, 2000
Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancerM Widschwendter, J Berger, M Hermann, et al.
Pageof 6